Chenggui Miao

1.7k total citations
63 papers, 1.3k citations indexed

About

Chenggui Miao is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Chenggui Miao has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 28 papers in Cancer Research and 12 papers in Rheumatology. Recurrent topics in Chenggui Miao's work include Cancer-related molecular mechanisms research (22 papers), Circular RNAs in diseases (17 papers) and MicroRNA in disease regulation (16 papers). Chenggui Miao is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), Circular RNAs in diseases (17 papers) and MicroRNA in disease regulation (16 papers). Chenggui Miao collaborates with scholars based in China, Hong Kong and United States. Chenggui Miao's co-authors include Jun Chang, Xu He, Yan Huang, Cheng Zhi Huang, Yingying Yang, Yong Jin, Xiongwen Lv, Jun Li, Wanwan Zhou and Youyi Xiong and has published in prestigious journals such as Biochemical Pharmacology, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Chenggui Miao

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenggui Miao China 21 829 502 259 172 160 63 1.3k
María Isabel Guillén Spain 21 667 0.8× 182 0.4× 364 1.4× 133 0.8× 97 0.6× 33 1.3k
Yasunori Tsubouchi Japan 17 853 1.0× 446 0.9× 190 0.7× 259 1.5× 201 1.3× 32 1.7k
Yan Meng China 18 584 0.7× 176 0.4× 65 0.3× 216 1.3× 101 0.6× 41 1.2k
Jianjun Zhu China 21 1.2k 1.4× 357 0.7× 49 0.2× 282 1.6× 210 1.3× 59 1.8k
Yingjie Guan China 21 1.1k 1.3× 354 0.7× 200 0.8× 312 1.8× 543 3.4× 46 1.8k
Jia Fu China 20 653 0.8× 181 0.4× 91 0.4× 313 1.8× 145 0.9× 58 1.6k
Yu-Chuen Huang Taiwan 20 529 0.6× 131 0.3× 80 0.3× 93 0.5× 113 0.7× 59 1.2k
Monika Gjorgjieva Switzerland 14 691 0.8× 590 1.2× 106 0.4× 89 0.5× 32 0.2× 22 1.1k

Countries citing papers authored by Chenggui Miao

Since Specialization
Citations

This map shows the geographic impact of Chenggui Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenggui Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenggui Miao more than expected).

Fields of papers citing papers by Chenggui Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenggui Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenggui Miao. The network helps show where Chenggui Miao may publish in the future.

Co-authorship network of co-authors of Chenggui Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Chenggui Miao. A scholar is included among the top collaborators of Chenggui Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenggui Miao. Chenggui Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hui, et al.. (2025). Vaccarin treats lactation insufficiency through the ALKBH5-SFRP2-Wnt/β-catenin signaling pathway. Journal of Ethnopharmacology. 348. 119898–119898.
2.
Zhou, Xinyue, Hui Li, Xiao Hua Wang, et al.. (2025). Clematichinenoside AR alleviates rheumatoid arthritis by inhibiting synovial angiogenesis through the HIF-1α/VEGFA/ANG2 axis. Phytomedicine. 139. 156552–156552. 6 indexed citations
3.
Peng, Yanhui, et al.. (2024). Associations between rheumatoid arthritis and intestinal flora, with special emphasis on RA pathologic mechanisms to treatment strategies. Microbial Pathogenesis. 188. 106563–106563. 11 indexed citations
4.
Wang, Yuting, et al.. (2023). Epigenetic modification and exosome effects on autophagy in osteoarthritis. Biochemical Pharmacology. 218. 115930–115930. 8 indexed citations
5.
Li, Chen, Yuting Wang, Hui Li, et al.. (2023). RNA methylations in depression, from pathological mechanism to therapeutic potential. Biochemical Pharmacology. 215. 115750–115750. 10 indexed citations
6.
Peng, Yanhui, Hui Li, Chen Li, et al.. (2023). Wilforine inhibits rheumatoid arthritis pathology through the Wnt11/β-catenin signaling pathway axis. Arthritis Research & Therapy. 25(1). 243–243. 10 indexed citations
7.
Wang, Xiao, Dexi Zhou, Wanwan Zhou, et al.. (2022). Clematichinenoside AR inhibits the pathology of rheumatoid arthritis by blocking the circPTN/miR-145-5p/FZD4 signal axis. International Immunopharmacology. 113(Pt A). 109376–109376. 31 indexed citations
8.
Wang, Xiaomei, Guoliang Zhou, Wanwan Zhou, et al.. (2021). Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics. 13(10). 1644–1644. 19 indexed citations
9.
Miao, Chenggui, Liangliang Bai, Yaru Yang, & Huang Jinling. (2021). Dysregulation of lncRNAs in Rheumatoid Arthritis: Biomarkers, Pathogenesis and Potential Therapeutic Targets. Frontiers in Pharmacology. 12. 652751–652751. 38 indexed citations
10.
Xiong, Youyi, et al.. (2019). Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis. Journal of Pharmacological Sciences. 139(3). 201–208. 6 indexed citations
11.
Miao, Chenggui, et al.. (2018). [Experimental Study on Paeoniflorin Inhibiting mTOR Signaling Pathway in Adjuvant Arthritis Rats].. PubMed. 49(4). 535–539. 3 indexed citations
12.
Miao, Chenggui, et al.. (2018). CUL4B promotes the pathology of adjuvant-induced arthritis in rats through the canonical Wnt signaling. Journal of Molecular Medicine. 96(6). 495–511. 21 indexed citations
13.
Ma, Shitang, et al.. (2018). The Herb‐Drug Interaction of Clopidogrel and Xuesaitong Dispersible Tablet by Modulation of the Pharmacodynamics and Liver Carboxylesterase 1A Metabolism. Evidence-based Complementary and Alternative Medicine. 2018(1). 5651989–5651989. 10 indexed citations
14.
Miao, Chenggui, et al.. (2017). [Molecular mechanism of total flavonoids in Isodon amethystoides on adjuvant arthritis in rats].. PubMed. 42(17). 3411–3416. 1 indexed citations
15.
Xiong, Youyi, Junsong Wang, Hao Yu, Xiaolin Zhang, & Chenggui Miao. (2015). Anti-asthma potential of crocin and its effect on MAPK signaling pathway in a murine model of allergic airway disease. Immunopharmacology and Immunotoxicology. 37(3). 236–243. 34 indexed citations
16.
Xiong, Youyi, et al.. (2014). The effects of nodakenin on airway inflammation, hyper-responsiveness and remodeling in a murine model of allergic asthma. Immunopharmacology and Immunotoxicology. 36(5). 341–348. 19 indexed citations
17.
Miao, Chenggui, et al.. (2013). [Chuju total flavonoids control the SFRP4 expression in Wnt pathway in rheumatoid arthritis model rats].. PubMed. 38(7). 715–21. 1 indexed citations
18.
Miao, Chenggui, Yingying Yang, Xu He, et al.. (2013). Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cellular Signalling. 25(10). 2069–2078. 167 indexed citations
19.
Miao, Chenggui, Yingying Yang, Xu He, et al.. (2013). New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. Cellular Signalling. 25(5). 1118–1125. 48 indexed citations
20.
Miao, Chenggui, Cheng Huang, Yan Huang, et al.. (2012). MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats. Cellular Signalling. 25(3). 598–608. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026